Product group 11 - aids against decubitus, product group 18 - vehicles for the sick / disabled and product group 24 - prosthetic legs has been updated in the German medical technical aids directory. The updates of the product groups was published in the Federal Gazette according to § 139 (1) SGB V on 19.02.2024.
PG 11 - "Aids against decubitus"
- Die Produktgruppe wird an den aktuellen medizintechnischen und den aktuellen medizinisch-pflegewissenschaftlichem Standard angepasst. Hierfür sind sowohl strukturelle als auch redaktionelle Anpassungen erforderlich. Nach Abschluss der Fortschreibung dieser Produktgruppe beabsichtigt der GKV-SV entsprechende Umgruppierungen im Rahmen der Verwaltungsaktverfahren vorzunehmen. Dies betrifft insbesondere Produkte, die in Produktarten mit der Kennzeichnung ‚Nicht besetzt‘ gelistet sind. Hersteller die von Umgruppierungen betroffen sind, sollten wachsam sein.
- Deletions and additions have been made to clarify and update the product type description, reflecting the current state of medical technology.
- New product types have been introduced to reflect the current state of medical technology:
- 11.29.13.0 "Mattresses, foam-air cell component combination"
- 11.39.04.5 "Structured seat cushion with spacer fabric"
PG 18 „Kranken- / Behindertenfahrzeuge“
- Since the last update in 2018, several new products have been added that could not be assigned to any existing product type. As a result, new product subgroups and types have been created, including demountable and self-balancing products.
- The quality requirements for the relevant product subgroups have been updated to align with the current status of the EN 2022 standard.
PG 24 - "Prosthetic legs"
- A number of new service items were added to existing product types.
- A number of new product types have been created.
- Deletions and additions have been made for clarification and updating.
- Clarifications and adjustments to the current state of the art have been made.
There are a number of other details in the editorial adaptation that we cannot go into here. Our recommendation to all manufacturers affected: Take a look at your portfolio and see if any action is needed. When in doubt, it is better to ask too many questions than too few. You can find more information under GKV-SV.